

















https://doiShort-Term Clinical Outcomes and Comparison of
Ultrasound Versus Magnetic Resonance Imaging of
Superior Capsular Reconstruction
Brian L. Badman, M.D., Aaron M. Baessler, M.D., and Molly Moor, Ph.D., M.P.H.Purpose: To evaluate the short-term outcomes of 10 patients with irreparable massive rotator cuff tears treated with
arthroscopic superior capsular reconstruction (SCR) using dermal allograft. Methods: Between 2016 and 2018, patients
with symptomatic irreparable rotator cuff tears were prospectively enrolled for treatment with arthroscopic SCR.
Investigational review board approval was achieved. All patients were treated by a single fellowship-trained shoulder
surgeon. Minimum follow-up was 1 year. Range of motion and functional outcome according to visual analog scale
pain, American Shoulder and Elbow Surgeons, and Simple Shoulder Test scores were assessed preoperatively and at
routine follow-up intervals. Magnetic resonance imaging (MRI) and ultrasound were obtained at a minimum of 1 year
to assess graft integrity and to correlate clinical outcomes. Results: Ten patients with a mean age of 58.6 years had a
minimum follow-up of 1 year. In all patients, preoperatively to postoperatively, mean forward flexion improved from
141 to 173 (P ¼ .018), mean visual analog scale pain score decreased from 6.5 to 1 (P ¼ .004), and mean American
Shoulder and Elbow Surgeons score improved from 43 to 87 (P ¼ .005). At 1 year, ultrasound evaluation identified graft
failure in 1 patient (10%), whereas MRI diagnosed graft failure in 7 patients (70%). Of the 7 failures diagnosed by MRI,
4 failed at the level of the glenoid, 2 failed mid-graft, and 1 failed at the humerus. Conclusions: Although clinical
outcomes are statistically improved following arthroscopic SCR using a dermal allograft, the early high failure rates of
the graft raise concerns about the long-term outcomes of the procedure. Furthermore, the use of ultrasound alone to
validate an intact graft should be used with caution, as failures can occur at the glenoid and can be missed without MRI
correlation. Level of Evidence: Level IV, Therapeutic case seriesuperior capsular reconstruction (SCR) has beenSadvocated as an effective technique for the man-
agement of massive irreparable rotator cuff tears,
particularly in younger, active patients.1-4 There are
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Arthroscopy, Sports Medicine, and Rehabilitationirreparable rotator cuff tears improves stability and
function of the shoulder joint.1,4,5 Despite the
increasing popularity of the technique, only a relatively
small number of patients in a few retrospective
studies6,7 and prospective studies5,8-10 exist regarding
overall outcomes of the procedure.
Fascia lata autograft was the original graft that was
described for the technique for arthroscopic SCR.1,5
Dermal allograft for SCR was later proposed as an
alternative, as it reduces donor-site morbidity and
overall surgical time.11 Dermal allograft remains the
most popular graft used in arthroscopic SCR. Only a few
available studies have examined the survivability of the
graft in patients, particularly with magnetic resonance
imaging (MRI) techniques.5,6,7-9 Little is known
regarding SCR dermal allograft integrity in patients by
ultrasound (US).
US evaluation can be useful in the postoperative
evaluation of rotator cuff repairs.12-14 There are ad-
vantages of the use of US in the postoperative shoulder
examination. US evaluation allows for a dynamic ex-
amination of the shoulder and can be reliably, Vol 2, No 3 (June), 2020: pp e229-e235 e229
e230 B. L. BADMAN ET AL.performed in the office. US is highly operator
dependent, however. MRI evaluation of the shoulder,
however, is a static examination and is more costly and
time-consuming.
The purpose of this study was to evaluate the short-
term outcomes of 10 patients with irreparable massive
rotator cuff tears treated with arthroscopic SCR using
dermal allograft. We hypothesized that SCR with
dermal allograft would lead to significant improve-
ments in clinical and functional patient outcomes and
that the majority of dermal allografts would remain
intact by MRI and US evaluation.Methods
Between 2016 and 2018, patients with symptomatic
irreparable rotator cuff tears were prospectively
enrolled for treatment with arthroscopic SCR with
dermal allograft. Informed consent and investigational
review board approval was achieved for the purposes of
the study (Salus IRB). All patients were treated by a
single fellowship-trained shoulder surgeon. Range of
motion and functional outcome were measured by the
treating surgeon according to American Shoulder and
Elbow Surgeons (ASES) score,15 Simple Shoulder Test
(SST),16,17 and visual analog scale (VAS) pain18 score
were assessed preoperatively and at routine follow-up
intervals. Inclusion criteria included all patients
treated with arthroscopic SCR with dermal allograft.
Exclusion criteria included patients revised to reverse
shoulder arthroplasty during the study period. Mini-
mum follow-up was 1 year. All patients were managed
preoperatively with maximum conservative measures
and then were referred for arthroscopic SCR after
conservative measures failed. This included periodic use
of steroid in all patients. No patient was offered surgery
within 3 months of recent injection.
Preoperatively, plain radiographs and MRI were ob-
tained in all patients to confirm the presence of massive
irreparable rotator cuff tears without significant gleno-
humeral degenerative change. In-office US was used
preoperatively in those patients that did not arrive to
their initial clinic visit with MRI confirmation of a tear.
From standard radiographs, acromial humeral distance
(millimeters) was radiographically measured preoper-
atively and 12 months postoperatively on a standard
Grashey shoulder view. Shoulders were graded ac-
cording to the well-described Hamada classifica-
tion.19,20 Preoperative MRI was used additionally to
assess the presence of a tangent sign and the degree of
fatty degeneration of rotator cuff musculature, accord-
ing to the Goutallier classification.21,22 All classifications
and grading were made by the treating surgeon. Post-
operatively, US and MRI evaluation of the shoulder
were obtained at a minimum of 1 year to assess graft
integrity and to correlate clinical outcomes.Our surgical technique for arthroscopic SCR is similar
to previously described techniques.3,9 Before SCR, the
following were performed in all cases: subscapularis
evaluation and repair, if needed, biceps evaluation with
tenotomy or tenodesis, subacromial decompression
with acromioplasty, and remaining infraspinatus repair,
if possible. For SCR, each case used acellular dermal
allograft secured by 2 glenoid anchors and 4 greater
tuberosity anchors in a double-row configuration.
Convergence suture techniques were used on the pos-
terior aspect of the repair.
Postoperatively, the rehab protocol in place was very
similar to protocols used for large or massive rotator
cuff repairs with and without dermal augmentation. All
patients were typically immobilized in a sling for 6
weeks. Rehabilitation through passive motion occurred
between 4 and 8 weeks postoperatively. Patients would
undergo active-assisted motion between 8 and 10
weeks, and then patients would start active motion
after 10 weeks postoperatively. After 10 weeks, patients
were started on a graduated strengthening that focused
on deltoid, periscapular, and the posterior rotator cuff
musculature. Patients were allowed to progress as
tolerated thereafter.
Statistical Analysis
ManneWhitney U tests and Fisher exact tests were
used to compare patient characteristics between intact
and failed grafts. Wilcoxon signed-rank tests were
performed to compare preoperative and 1-year post-
operative outcomes. Data were analyzed using SPSS,
version 25 (IBM Corp., Armonk, NY). All statistical tests
were 2-tailed. Significance was set at P < .05.
Results
Ten patients were prospectively enrolled into the
study. Ten patients with a mean age of 58.6 years had a
minimum follow-up of 1 year. Two patients (20%) had
a previous rotator cuff repair. No patients were revised
to reverse shoulder arthroplasty during the study
period. Three patients were retired; the 7 remaining
patients returned to their job. No patient performed
strenuous manual labor.
At 1 year, all patients had both US and MRI to assess
graft integrity. US identified graft failure in 1 patient
(10%), whereas MRI identified graft failure in 7 pa-
tients (70%). As a diagnostic tool in this setting, US had
a sensitivity of 14%, specificity of 100%, positive pre-
dictive value of 100%, negative predictive value of
33%, and accuracy of 40%. Of the 7 failures based on
MRI, 4 failed at the level of the glenoid, 2 failed mid
graft, and 1 failed at the humerus. Figure 1 provides
examples of corresponding US and MRI images of pa-
tients with intact and failed grafts.
Table 1 lists the patient demographics as well as scores
from VAS pain, SST, and ASES questionnaires in
Fig 1. US and MRI of selected
intact and failed grafts. US and
MRI were performed in all pa-
tients at 1 year following superior
capsular reconstruction with
dermal allograft. Single coronal
images of corresponding US and
T1-weighted MRI are shown from
left to right in 4 separate patients.
Structures in the US images are
labeled as D (deltoid), G (graft), H
(humerus). (A), US shows an
intact graft, whereas MRI in the
same patient shows graft failure
mid-graft. (B), US shows an intact
graft, whereas MRI in the same
patient reveals graft failure at the
glenoid. (C), US shows complete
graft failure along with a confir-
matory corresponding MRI. (D),
images demonstrate an intact
graft on both US and MRI in the
same patient. (MRI, magnetic
resonance imaging; US,
ultrasound.)
CLINICAL AND IMAGING OUTCOMES AFTER SCR e231patients with intact grafts versus failed grafts. Age was
greater in the intact group at 68.7 years compared with
54.3 years for the graft failure group (P ¼ .022). Sex
was similar between groups (P ¼ .524). At 1 year
postoperatively, there was no significant difference in
VAS pain score (P ¼ .123), SST score (P ¼ .562), ASESscore (P ¼ .909), abduction motion (P ¼ .673), or for-
ward flexion motion (P ¼ .416) in patients with an
intact graft versus those with a failed graft.
In all patients preoperatively to 1 year post-
operatively, mean forward flexion improved from 141
to 173 (P ¼ .018), mean abduction improved from
Table 1. Comparison of Characteristics Between Patients










or n (%) P Value
Age, y 68.7  7.1 54.3  4.2 .022
Male sex 1 (33.3) 4 (57.1) .490
Previous surgery 0 (0) 2 (28.6) .301
Operative side >0.999
Right 2 (66.7) 6 (85.7)
Left 1 (33.3) 1 (14.3)
VAS pain
Preoperative 5  0 7  2.1 .271
12 months postoperative 0  0 1.5  2.1 .123
SST
Preoperative 3.3  1.5 5.6  3.1 .353
First postoperative 2.3  1.5 2  1.4 .791
6 weeks postoperative 3  0 4.3  1.8 .359
3 months postoperative 5  1 8.1 2 .063
6 months postoperative 8.7  0.6 9.1  2.9 .725
12 months postoperative 9.7  2.1 10.3  2.1 .562
ASES Shoulder Score
Pre-op 38.3  7.6 44.7  11.6 .487
First postoperative 48.3  17.2 42  9.7 .563
6 weeks postoperative 55  2.8 44.9  9.4 .140
3 months postoperative 69.7  13.7 67.3  8.8 .646
6 months postoperative 88.7  1.2 80  14.1 .435
12 months postoperative 90  8.9 86.1  12.3 .909
Forward flexion ROM,
Preoperative 120  87 148  31 >0.999
12 months postoperative, 163  29 176  10 .416
Abduction ROM
Preoperative 130  86.6 135  55.2 .663
12 months postoperative 150  52 173  12.2 .673
ASES, American Shoulder and Elbow Surgeons, MRI, magnetic
resonance imaging; ROM, range of motion; SD, standard deviation;
SST, Simple Shoulder Test; VAS, visual analog scale.
e232 B. L. BADMAN ET AL.134 to 166 (P ¼ .048), mean VAS pain decreased from
6.5 to 1.0 (P ¼ .004), SST improved from 4.9 to 10 (P ¼
.005), and ASES improved from 43 to 87 (P ¼ .005)
(Table 2). For those patients with an intact graft at 1
year, VAS pain decreased from 5 to 0 (P ¼ .083), SST
improved from 3.3 to 9.7 (P ¼ .109), ASES improved
from 38.3 to 90.0 (P ¼ .109), abduction improved from
130 to 150 (P ¼ .317), and forward flexion improved
from 120 to 163 (P ¼ .18). For those patients with a
failed graft at 1 year, VAS pain decreased from 7.0 to
1.5 (P ¼ .017), SST improved from 5.5 to 10 (P ¼ .017),
ASES improved from 44.5 to 86 (P ¼ .018), abduction
improved from 135 to 173 (P ¼ .084), and forward
flexion improved from 149 to 176 (P ¼ .043).
Table 3 compares the preoperative imaging charac-
teristics as well as the intraoperative findings in patients
with intact and failed grafts based on their 1-year
postoperative MRI. There were no significant differ-
ences between the groups based on Goutallier classifi-
cation of the supraspinatus (P ¼ .667), infraspinatus(P ¼ 1.0), or subscapularis (P ¼ 1.0). The tangent sign
was present preoperatively in all patients with an intact
graft and 71% of patients with a failed graft (P ¼ 1.0).
Between the groups, all patients were grade 1 or 2
based on the Hamada classification (P ¼ 1.0). Preop-
eratively, average acromial humeral distance was 7.4
mm and 6.6 mm for those with intact and failed grafts
at 1 year, respectively (P ¼ .568). At 1 year, this mea-
surement was 6.6 mm and 6.0 mm for those with intact
and failed grafts, respectively (P ¼ .493). There were no
differences in the intraoperative rotator cuff tear
pattern or residual tendon length between those pa-
tients with an intact and failed graft at 1 year (P ¼ .65
and P ¼ .569, respectively). Performing repair of sub-
scapularis or infraspinatus along with biceps manage-
ment showed no difference between those with intact
or failed grafts (P ¼ 1.0, P ¼ 1.0, and P ¼ 1.0,
respectively).
Discussion
The findings within this study support the first portion
of our hypothesis in that there was a significant
improvement in clinical and functional outcomes at 1
year in all patients treated with arthroscopic SCR with
dermal allograft. However, the second portion of our
hypothesis was refuted in that 7 of 10 patients (70%)
demonstrated that the graft had failed at 1 year by MRI
evaluation. Despite graft failures, range of motion and
clinical and functional outcome scores improved and
trended toward significance even in these patients.
There were no significant preoperative radiographic or
intraoperative differences between those patients with
an intact or failed graft at o1 year.
In our study, the improvement in forward
flexion,5,9,10 VAS,6,8-10 and ASES5,6,8-10 scores was
similar to previously published studies. When looking
at graft failure and re-tear, there are a wide range of
reported values for failure. A case study by Zerr et al.23
in 2017 reported on an SCR with dermal allograft that
failed at the glenoid based on MRI findings. Denard
et al.9 performed MRI on a subset (20 of 59) of patients
and determined that dermal allograft failure occurred in
55% (11 of 20 with the MRI) of those cases. In 2018,
Lee and Min10 had performed MRI on all patients and
reported a re-tear rate of 36.1% (13/36) for SCRs with
dermal allograft between 6 and 12 months post-
operatively. Contrary to our results, failures in both of
these studies most often occurred on the humeral side
rather than the glenoid side of the graft.9,10 Pennington
et al.6 reported a 4.5% clinical failure rate (4/88) and
3.4% radiographic failure rate (3/88) on MRI with
dermal allograft, although only a small subset of those
patients who were dissatisfied (4/88) were imaged. So,
of the 4 shoulders imaged in that study, 75% (3 of 4)
showed failure radiographically. If we combine the re-
sults of all SCRs with dermal allograft in patients who
Table 2. Preoperative and 1-Year Postoperative Comparisons Among Patients With Intact and Failed Grafts Diagnosed by MRI
Variable
Preoperative,
Mean  SD or n (%)
12 Months’ Postoperative,
Mean  SD or n (%) P Value
Intact graft (n ¼ 3)
VAS 5  0 0  0 .083
SST 3.3  1.5 9.7  2.1 .109
ASES Shoulder Score 38.3  7.6 90  8.9 .109
Forward flexion ROM, 120  87.2 163  28.9 .180
Abduction ROM, 130  86.6 150  52 .317
Acromial humeral distance, mm 7.4  2.0 6.6  1.4 .285
Failed graft (n ¼ 7)
VAS 7  2.1 1.5  2.1 .017
SST 5.5  3.1 10  2.1 .017
ASES Shoulder Score 44.5  11.6 86  10.2 .018
Forward flexion ROM, 149  28.3 176  10.2 .043
Abduction ROM, 135  55.2 173  12.2 .084
Acromial humeral distance, mm 6.6  1.7 6  1.2 .150
Intact and failed grafts combined (n ¼ 10)
VAS 6.5  1.9 1  1.8 .004
SST 4.9  2.8 10  2.0 .005
ASES Shoulder Score 43  10.6 87  11.1 .005
Forward flexion ROM, 141  49 173  17 .018
Abduction ROM, 134  60.8 166  28.7 .048
Acromial humeral distance, mm 6.8  1.7 6.2  1.2 .052
ASES, American Shoulder and Elbow Surgeons, MRI, magnetic resonance imaging; ROM, range of motion; SD, standard deviation; SST, Simple
Shoulder Test; VAS, visual analog scale.
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studies by Denard et al., Lee and Min, and Pennington
et al., 45% (27 of 60) of grafts failed on imaging, which
is a fairly high rate of radiographic failure that is similar
to the present study. Compared with the use of SCR
with dermal allograft, the literature on SCR with fascia
lata autografts is less abundant but may lead to some
insight into radiographic graft failure. Mihata et al.24
showed that only 5% (5/100) of fascia lata autografts
were torn on MRI by at least 2 years. The clinical and
radiographic success of the use of autografts in this
procedure may not be applicable to the use of allografts
in this procedure.25
US has been used reliably in the postoperative eval-
uation of rotator cuff repairs.12-14 Until recently, little
was known regarding the utility of US in evaluation of
healing after arthroscopic SCR. Hirahara et al.8
demonstrated that between 4 and 8 months after
SCR, US can reveal pulsatile vessels within the allograft
tissue, signifying incorporation and healing of the graft
tissue. The present study used US to examine graft
integrity in all patients and found that 1 of 10 patients
had failure of the graft on US. However, when MRI was
performed on all patients, an additional 6 graft failures
were identified. Of the 7 graft failures, 4 total failures
were at the glenoid, 2 failures were mid-graft, and 1
was at the level of the humerus. With poor sensitivity
(14%), negative predictive value (33%), and overall
accuracy (40%), US should not be used alone to vali-
date an intact graft, as failures are often missed on this
imaging modality. Despite a radiologic graft failure rate
of 70%, all patients demonstrated clinical andfunctional improvement, which is consistent with data
from available literature.
Limitations
There were several limitations to our study. First,
follow-up data were only available for 1 year post-
operatively. Long term, the data are unclear on the
viability of SCR. Second, this study included a small
sample size. This limited the ability to detect significant
differences between patients with and without graft
failure. A post-hoc power analysis revealed that greater
than 80% power was achieved among both intact and
failed graft groups in the preoperative to postoperative
comparisons involving VAS pain, SST, and ASES;
however, a minimum of 80% power was not achieved
for range of motion or radiographic comparisons.
Interestingly, when pooling all patients together, sta-
tistically significant preoperative to postoperative im-
provements were evident in almost all categories,
despite limited power. Third, this study only used one
fellowship-trained shoulder surgeon, who used dermal
allograft for SCR procedures. There may be subtle
variances in surgical technique between other surgeons
that could lead to better radiographic outcomes, and the
choice of graft may affect healing and graft
incorporation.
Conclusions
Although clinical outcomes are statistically improved
following arthroscopic SCR using a dermal allograft, the
early high failure rates of the graft raise concerns about
the long-term outcomes of the procedure.
Table 3. Comparison of Preoperative Imaging and Intraoperative Characteristics Between Patients With Intact and Failed Grafts
Diagnosed by MRI at 1 Year
Variable
Intact Graft (n ¼ 3),
Mean  SD or n (%)
Graft Failure (n ¼ 7),
Mean  SD or n (%) P Value
Goutallier supraspinatus classification .667
Stage 0 0 (0) 0 (0)
Stage 1 0 (0) 0 (0)
Stage 2 0 (0) 1 (14.3)
Stage 3 2 (66.7) 2 (28.6)
Stage 4 1 (33.3) 4 (57.1)
Goutallier subscapularis classification >.999
Stage 0 3 (100) 7 (100)
Stage 1 0 (0) 0 (0)
Stage 2 0 (0) 0 (0)
Stage 3 0 (0) 0 (0)
Stage 4 0 (0) 0 (0)
Goutallier infraspinatus classification >.999
Stage 0 1 (33.3) 2 (28.6)
Stage 1 1 (33.3) 1 (14.3)
Stage 2 1 (33.3) 3 (42.8)
Stage 3 0 (0) 1 (14.3)
Stage 4 0 (0) 0 (0)
Positive tangent sign 3 (100) 5 (71.4) >.999
Hamada classification 1.00
Grade 1 2 (66.7) 3 (42.9)
Grade 2 1 (33.3) 4 (57.1)
Grade 3 0 (0) 0 (0)
Grade 4 0 (0) 0 (0)
Grade 5 0 (0) 0 (0)
Acromial humeral distance, mm
Preoperative 7.4  2.0 6.6  1.7 .568
12 months’ postoperative 6.6  1.4 6.0  1.2 .493
Tear pattern .650
Supraspinatus 1 (33.3) 3 (42.8)
Supraspinatus and subscapularis 0 (0) 2 (28.6)
Supraspinatus and infraspinatus 1 (33.3) 2 (28.6)
Supraspinatus and subscapularis and infraspinatus 1 (33.3) 0 (0)
Residual tendon length, mm 11.8  4.4 10.1  2.3 .569
Subscapularis repaired 1 (33.3) 1 (14.3) >.99
Infraspinatus repaired 2 (66.7) 3 (42.9) >.999
Biceps management >.999
Tenotomy 0 (0) 1 (14.3)
Ruptured 3 (100) 6 (85.7)
MRI, magnetic resonance imaging; SD, standard deviation.
e234 B. L. BADMAN ET AL.Furthermore, the use of US alone to validate an intact
graft should be used with caution, as failures can occur
at the glenoid and can be missed without MRI
correlation.References
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